All News

Living beyond the statistics and finding a way to celebrate a “cancerversary” with metastatic breast cancer.

The company has withdrawn the small cell lung cancer indication for Opdivo (nivolumab) based on discussions with the FDA, particularly focused on post-market studies that missed their primary endpoints of overall survival.

In participants who reported that the pandemic negatively impacted their decision to enroll in a clinical trial, some of the most common reasons included exposure to the virus and limited access to care.

Waiting is the hardest part when wondering about cancer complications.

In an interview with CURE®, Dr. Wade T. Iams discussed small cell lung cancer, a subtype of lung cancer that starts from neuroendocrine cells in the lung, how different stages are treated and the potential benefits of having a treatment team to communicate with every step of the way.

Here are the top 10 most popular contributor articles from 2020!

A roundup of some of the most read news and updates in breast cancer in 2020 from CURE®.

No matter the challenge, oncology nurses look to help you out.

A song can be the gateway to memories on the cancer journey.

Here is a list of some recent trials that launched within the cancer space in December.

A roundup of some of the most read news and updates in follicular lymphoma in 2020 from CURE®.

The Food and Drug Administration lifted a clinical hold on the MELANI-01 trial, evaluating UCARTCS1A, a CAR T-cell product in patients with relapsed or refractory multiple myeloma.

Sometimes it’s hard to bring up the many side effects of cancer treatment, but talking about them can help your doctor provide the best care.

The study found that the risk increased despite receiving care at a highly specialized center, although neighborhood poverty did not have the same degree of impact on children with the nonmalignant disease.

Here are the top 10 stories from CURE® in 2020.

In an interview with CURE®, Dr. Irene M. Ghobrial discussed smoldering myeloma, a precursor condition that may progress to multiple myeloma, how to proceed if diagnosed with the condition and the available opportunities to participate in clinical trials to learn more.

A roundup of some of the most read news and updates in mantle cell lymphoma in 2020 from CURE®.

A cancer survivor describes the dark days we are facing right now and expresses a ray of hope for all.

Both younger and older women being treated for early breast cancer with chemotherapy are experiencing the same levels of symptom severity and find it a great concern as it interferes with their daily activities.

Here are the top 10 FDA oncology drug approvals that you may have missed this year.

Women with ovarian cancer report a better quality of life when treated with a combination of Keytruda, Avastin and oral metronomic cyclophosphamide.

Highlighting a positive prognosis and improving education in treatment risk could result in lowering the overtreatment of older women who develop early-stage, hormone receptor-positive breast cancer.

Sometimes the only way to get over something is through, and cancer is no different. A survivor gives his perspective on gutting out treatment for cancer.

National guidelines recommend initial surveillance colonoscopy one year after colorectal cancer surgery, but only 57.5% of patients received one in this study due to racial disparities.

Every now and then CURE® is able to get a celebrity to talk about their experience with cancer and share how this common disease even impacts them.

It’s excruciating for a person to hear their cancer diagnosis, and they need their caregiver to help them through it. Here are 8 tips from a cancer survivor for first-time caregivers.

Here are the top 10 episodes of the “CURE Talks Cancer” podcast from 2020.

A roundup of some of the most read news and updates in acute myeloid leukemia in 2020 from CURE®.

How an app supported by Alexa has helped me answer cancer questions.

From the Ohio state legislature tackling the “fail first” provision insurances put in place to keep patients with advanced cancer on generic drugs that are less effective to COVID-19 becoming the third leading cause of death in the United States behind cancer, here’s what happened in the cancer landscape this week.